Dexketoprofen Trometamol in Postoperative Endodontic Pain
Launched by DANIEL CHAVARRÍA BOLAÑOS · Mar 11, 2014
Trial Information
Current as of May 10, 2025
Completed
Keywords
ClinConnect Summary
Pain management is an integral part of Endodontics, according to previously published results, pulp therapy and endodontic treatment induce postoperative pain more frequently than other dental procedures.
The prevalence of postoperative pain has been reported in 3-58% of cases, a positive association has been demonstrated between postoperative pain and the presence of apprehension and preoperative pain.
Although the incidence of moderate pain decreases within 1 day and substantially to minimal levels in 7 days after the endodontic treatment, severe postoperative pain occurs during the fir...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects aged 18 years and older with moderate-to-severe dental pain assessed by numerical rating scale (NRS) associated with irreversible pulpitis.
- Exclusion Criteria:
- • • Female pregnant or breastfeeding
- • Used pain relievers or anti-inflammatory drugs within 24 hours preceding emergency endodontic treatment
- • Have any significant medical condition
- • Taking any medications for anxiety, depression or schizophrenia
- • Have a history of hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)
About Daniel Chavarría Bolaños
Daniel Chavarría Bolaños is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the design and management of clinical studies, he focuses on innovative therapeutic interventions across various therapeutic areas. His approach emphasizes rigorous scientific methodology, ethical standards, and collaboration with healthcare professionals to ensure the highest quality of data and participant safety. Daniel is passionate about fostering a culture of transparency and integrity in clinical research, making significant contributions to the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Luis Potosi, , Mexico
Patients applied
Trial Officials
Gisela Rodríguez, DDS
Principal Investigator
Universidad Autonoma San Luis Potosi
Amaury J Pozos-Guillen, PhD
Study Chair
Universidad Autonoma San Luis Potosi
Daniel Chavarria, PhD
Study Director
Universidad Autonoma San Luis Potosi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials